FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
|Videos|July 3, 2013
The Use of Specialty Tiers
Debbie Stern of Rxperts discusses the findings from the EMD Serono Specialty Digest, 9th Edition, and the use of specialty drug tiers by payers.
Advertisement
Debbie Stern of Rxperts discusses the findings from the EMD Serono Specialty Digest, 9th Edition, and the use of specialty drug tiers by payers. Video taken at the 2013 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
For more on this topic and a full review of the report, see:
Advertisement
Related to this article
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
4
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
5